{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:57:07Z","timestamp":1791309427371,"version":"4.3.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Adenoid Cystic Carcinoma Research Foundation, United States"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"DOI":"10.1007\/s12105-024-01719-1","type":"journal-article","created":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T04:03:16Z","timestamp":1729915396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparative Analysis of MYB Expression by Immunohistochemistry and RNA Sequencing in Clinical Gene Fusion Detection in Adenoid Cystic Carcinoma"],"prefix":"10.1007","volume":"18","author":[{"given":"Adam S.","family":"Fisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Thierauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Iafrate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen K.","family":"Lennerz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Faquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,26]]},"reference":[{"key":"1719_CR1","unstructured":"International Agency for Research on Cancer. WHO Classification of Tumours Editorial Board. Head and Neck Tumours [Internet]. [Cited 2024 May 14]. Vol 9. 5th ed (2023) https:\/\/tumourclassification.iarc.who.int\/chapters\/52"},{"issue":"2","key":"1719_CR2","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s12105-020-01210-7","volume":"15","author":"EF de Morais","year":"2021","unstructured":"de Morais EF, da Silva LP, Moreira DGL et al (2021) Prognostic factors and survival in adenoid cystic carcinoma of the Head and Neck: a Retrospective Clinical and histopathological analysis of patients seen at a Cancer Center. Head Neck Pathol 15(2):416\u2013424. https:\/\/doi.org\/10.1007\/s12105-020-01210-7","journal-title":"Head Neck Pathol"},{"issue":"8","key":"1719_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.oraloncology.2014.04.008","volume":"50","author":"G Stenman","year":"2014","unstructured":"Stenman G, Persson F, Andersson MK (2014) Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers. Oral Oncol 50(8):683\u2013690. https:\/\/doi.org\/10.1016\/j.oraloncology.2014.04.008","journal-title":"Oral Oncol"},{"issue":"6","key":"1719_CR4","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/PAS.0000000000001850","volume":"46","author":"EP Mathew","year":"2022","unstructured":"Mathew EP, Todorovic E, Truong T et al (2022) Metatypical adenoid cystic carcinoma: a variant showing prominent squamous differentiation with a predilection for the sinonasal tract and skull base. Am J Surg Pathol 46(6):816\u2013822","journal-title":"Am J Surg Pathol"},{"key":"1719_CR5","unstructured":"El-Naggar A, Chan J, Grandis J, Takata T, Slootweg P (2017) WHO classification of Head and Neck Tumours, 4th edn. IARC"},{"issue":"1","key":"1719_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.oraloncology.2014.10.007","volume":"51","author":"S van Weert","year":"2015","unstructured":"van Weert S, van der Waal I, Witte BI, Ren\u00e9 Leemans C, Bloemena E (2015) Histopathological grading of adenoid cystic carcinoma of the head and neck: analysis of currently used grading systems and proposal for a simplified grading scheme. Oral Oncol 51(1):71\u201376. https:\/\/doi.org\/10.1016\/j.oraloncology.2014.10.007","journal-title":"Oral Oncol"},{"issue":"2","key":"1719_CR7","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1097\/PAS.0000000000000980","volume":"42","author":"A Sk\u00e1lov\u00e1","year":"2018","unstructured":"Sk\u00e1lov\u00e1 A, Stenman G, Simpson RHW et al (2018) The role of molecular testing in the differential diagnosis of salivary gland carcinomas. Am J Surg Pathol 42(2):e11\u2013e27. https:\/\/doi.org\/10.1097\/PAS.0000000000000980","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1719_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.oraloncology.2005.06.014","volume":"42","author":"D Andreadis","year":"2006","unstructured":"Andreadis D, Epivatianos A, Poulopoulos A et al (2006) Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours. Oral Oncol 42(1):56\u201364. https:\/\/doi.org\/10.1016\/j.oraloncology.2005.06.014","journal-title":"Oral Oncol"},{"issue":"3","key":"1719_CR9","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1158\/1078-0432.CCR-15-2867-T","volume":"22","author":"Y Mitani","year":"2016","unstructured":"Mitani Y, Liu B, Rao PH et al (2016) Novel MYBL1 gene rearrangements with recurrent MYBL1\u2013NFIB fusions in salivary adenoid cystic carcinomas lacking t(6;9) Translocations. Clin Cancer Res 22(3):725\u2013733. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2867-T","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1719_CR10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41379-018-0008-8","volume":"31","author":"Y Togashi","year":"2018","unstructured":"Togashi Y, Dobashi A, Sakata S et al (2018) MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts. Mod Pathol 31(6):934\u2013946. https:\/\/doi.org\/10.1038\/s41379-018-0008-8","journal-title":"Mod Pathol"},{"issue":"1","key":"1719_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/PAS.0b013e3182002777","volume":"35","author":"RB West","year":"2011","unstructured":"West RB, Kong C, Clarke N et al (2011) MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation. Am J Surg Pathol 35(1):92\u201399. https:\/\/doi.org\/10.1097\/PAS.0b013e3182002777","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"1719_CR12","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/modpathol.2011.86","volume":"24","author":"LB Brill","year":"2011","unstructured":"Brill LB, Kanner WA, Fehr A et al (2011) Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod Pathol 24(9):1169\u20131176. https:\/\/doi.org\/10.1038\/modpathol.2011.86","journal-title":"Mod Pathol"},{"issue":"2","key":"1719_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-15-0859","volume":"6","author":"KJ Brayer","year":"2016","unstructured":"Brayer KJ, Frerich CA, Kang H, Ness SA (2016) Recurrent fusions in MYB and MYBL1 define a common, transcription factor\u2013driven oncogenic pathway in salivary gland adenoid cystic carcinoma. Cancer Discov 6(2):176\u2013187. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0859","journal-title":"Cancer Discov"},{"key":"1719_CR14","doi-asserted-by":"publisher","unstructured":"Thierauf J, Ramamurthy N, Jo VY et al Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma. The Oncologist. Published online 2019:theoncologist.2018\u2009\u2013\u20090515. https:\/\/doi.org\/10.1634\/theoncologist.2018-0515","DOI":"10.1634\/theoncologist.2018-0515"},{"issue":"6","key":"1719_CR15","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.3390\/ijms25063231","volume":"25","author":"KH Klempnauer","year":"2024","unstructured":"Klempnauer KH (2024) Transcription factor MYB as therapeutic target: current developments. Int J Mol Sci 25(6):3231. https:\/\/doi.org\/10.3390\/ijms25063231","journal-title":"Int J Mol Sci"},{"key":"1719_CR16","doi-asserted-by":"publisher","unstructured":"Hanna GJ, Grover P, Elliott A et al (2024) Molecular profiling and the impact of treatment on outcomes in adenoid cystic carcinoma (ACC) type-I and II. Clin Cancer Res Published Online Febr 28. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-3182","DOI":"10.1158\/1078-0432.CCR-23-3182"},{"issue":"2","key":"1719_CR17","first-page":"155","volume":"11","author":"DC Allred","year":"1998","unstructured":"Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol off J U S Can Acad Pathol Inc 11(2):155\u2013168","journal-title":"Mod Pathol off J U S Can Acad Pathol Inc"},{"issue":"12","key":"1719_CR18","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/nm.3729","volume":"20","author":"Z Zheng","year":"2014","unstructured":"Zheng Z, Liebers M, Zhelyazkova B et al (2014) Anchored multiplex PCR for targeted next-generation sequencing. Nat Med 20(12):1479\u20131484. https:\/\/doi.org\/10.1038\/nm.3729","journal-title":"Nat Med"},{"issue":"1","key":"1719_CR19","doi-asserted-by":"publisher","first-page":"15090","DOI":"10.1038\/srep15090","volume":"5","author":"P Kaspar","year":"2015","unstructured":"Kaspar P, Zikova M, Bartunek P et al (2015) The expression of c-Myb correlates with the levels of Rhabdomyosarcoma-specific marker myogenin. Sci Rep 5(1):15090. https:\/\/doi.org\/10.1038\/srep15090","journal-title":"Sci Rep"},{"issue":"8","key":"1719_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41416-021-01641-1","volume":"126","author":"SK Srivastava","year":"2022","unstructured":"Srivastava SK, Khan MA, Anand S et al (2022) MYB interacts with androgen receptor, sustains its ligand-independent activation and promotes castration resistance in prostate cancer. Br J Cancer 126(8):1205\u20131214. https:\/\/doi.org\/10.1038\/s41416-021-01641-1","journal-title":"Br J Cancer"},{"issue":"2","key":"1719_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/cancers11020235","volume":"11","author":"B Felipe-Abrio","year":"2019","unstructured":"Felipe-Abrio B, Verdugo-Sivianes EM, S\u00e1ez C, Carnero A (2019) Loss of MYBBP1A induces Cancer Stem Cell Activity in Renal Cancer. Cancers 11(2):235. https:\/\/doi.org\/10.3390\/cancers11020235","journal-title":"Cancers"},{"issue":"7","key":"1719_CR22","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.7150\/jca.27261","volume":"10","author":"R Xie","year":"2019","unstructured":"Xie R, Yang Y, Zhang H et al (2019) c-Myb and its Effector COX-2 as an Indicator Associated with Prognosis and Therapeutic Outcome in Colorectal Cancer. J Cancer 10(7):1601\u20131610. https:\/\/doi.org\/10.7150\/jca.27261","journal-title":"J Cancer"},{"issue":"7","key":"1719_CR23","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.7150\/jca.53689","volume":"12","author":"Q Liu","year":"2021","unstructured":"Liu Q, Wang Q, Lv C et al (2021) Brucine inhibits proliferation of glioblastoma cells by targeting the G-quadruplexes in the c-Myb promoter. J Cancer 12(7):1990\u20131999. https:\/\/doi.org\/10.7150\/jca.53689","journal-title":"J Cancer"},{"issue":"2","key":"1719_CR24","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1177\/0194599815584762","volume":"153","author":"K Kobayashi","year":"2015","unstructured":"Kobayashi K, Ando M, Saito Y et al (2015) Nerve growth factor signals as possible pathogenic biomarkers for Perineural Invasion in Adenoid cystic carcinoma. Otolaryngol Neck Surg 153(2):218\u2013224. https:\/\/doi.org\/10.1177\/0194599815584762","journal-title":"Otolaryngol Neck Surg"},{"issue":"7","key":"1719_CR25","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/PAS.0000000000000878","volume":"41","author":"JS Poling","year":"2017","unstructured":"Poling JS, Yonescu R, Subhawong AP et al (2017) MYB labeling by immunohistochemistry is more sensitive and specific for breast adenoid cystic carcinoma than MYB labeling by FISH. Am J Surg Pathol 41(7):973\u2013979. https:\/\/doi.org\/10.1097\/PAS.0000000000000878","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1719_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1200\/JCO.2016.67.5264","volume":"35","author":"R Ferrarotto","year":"2017","unstructured":"Ferrarotto R, Mitani Y, Diao L et al (2017) Activating NOTCH1 mutations define a distinct subgroup of patients with adenoid cystic Carcinoma who have poor prognosis, propensity to bone and liver metastasis, and potential responsiveness to Notch1 inhibitors. J Clin Oncol off J Am Soc Clin Oncol 35(3):352\u2013360. https:\/\/doi.org\/10.1200\/JCO.2016.67.5264","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"key":"1719_CR27","doi-asserted-by":"publisher","first-page":"105095","DOI":"10.1016\/j.oraloncology.2020.105095","volume":"113","author":"H Adderley","year":"2021","unstructured":"Adderley H, Rack S, Hapuarachi B et al (2021) The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinoma. Oral Oncol 113:105095. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.105095","journal-title":"Oral Oncol"},{"issue":"15","key":"1719_CR28","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.3390\/cancers14153691","volume":"14","author":"M Persson","year":"2022","unstructured":"Persson M, Andersson MK, Mitani Y et al (2022) Rearrangements, expression, and clinical significance of MYB and MYBL1 in adenoid cystic carcinoma: a multi-institutional study. Cancers 14(15):3691. https:\/\/doi.org\/10.3390\/cancers14153691","journal-title":"Cancers"},{"issue":"3","key":"1719_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng.3502","volume":"48","author":"Y Drier","year":"2016","unstructured":"Drier Y, Cotton MJ, Williamson KE et al (2016) An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nat Genet 48(3):265\u2013272. https:\/\/doi.org\/10.1038\/ng.3502","journal-title":"Nat Genet"},{"issue":"1","key":"1719_CR30","first-page":"227","volume":"9","author":"SM Jacobs","year":"1994","unstructured":"Jacobs SM, Gorse KM, Westin EH (1994) Identification of a second promoter in the human c-myb proto-oncogene. Oncogene 9(1):227\u2013235","journal-title":"Oncogene"},{"issue":"4","key":"1719_CR31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/PAS.0000000000001616","volume":"45","author":"LM Rooper","year":"2021","unstructured":"Rooper LM, Lombardo KA, Oliai BR, Ha PK, Bishop JA (2021) MYB RNA in situ hybridization facilitates sensitive and Specific Diagnosis of Adenoid Cystic Carcinoma regardless of translocation status. Am J Surg Pathol 45(4):488\u2013497. https:\/\/doi.org\/10.1097\/PAS.0000000000001616","journal-title":"Am J Surg Pathol"},{"key":"1719_CR32","doi-asserted-by":"publisher","unstructured":"Ueda K, Murase T, Kawakita D et al The landscape of MYB\/MYBL1- and peri-MYB\/MYBL1-associated rearrangements in adenoid cystic carcinoma. Mod Pathol Published Online July 2023:100274. https:\/\/doi.org\/10.1016\/j.modpat.2023.100274","DOI":"10.1016\/j.modpat.2023.100274"},{"key":"1719_CR33","doi-asserted-by":"publisher","first-page":"106763","DOI":"10.1016\/j.oraloncology.2024.106763","volume":"151","author":"J Huang","year":"2024","unstructured":"Huang J, Fehr A, J\u00e4wert F et al (2024) MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature. Oral Oncol 151:106763. https:\/\/doi.org\/10.1016\/j.oraloncology.2024.106763","journal-title":"Oral Oncol"},{"issue":"5","key":"1719_CR34","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3390\/cancers15051390","volume":"15","author":"KJ Brayer","year":"2023","unstructured":"Brayer KJ, Kang H, El-Naggar AK et al (2023) Dominant Gene expression profiles define adenoid cystic carcinoma (ACC) from different tissues: validation of a Gene Signature classifier for poor survival in salivary gland ACC. Cancers 15(5):1390. https:\/\/doi.org\/10.3390\/cancers15051390","journal-title":"Cancers"},{"issue":"1","key":"1719_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41389-020-0194-3","volume":"9","author":"MK Andersson","year":"2020","unstructured":"Andersson MK, Mangiapane G, Nevado PT et al (2020) ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma. Oncogenesis 9(1):5. https:\/\/doi.org\/10.1038\/s41389-020-0194-3","journal-title":"Oncogenesis"},{"issue":"2","key":"1719_CR36","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/1873-3468.14786","volume":"598","author":"Y Cicir\u00f2","year":"2024","unstructured":"Cicir\u00f2 Y, Ragusa D, Nevado PT et al (2024) The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS Lett 598(2):252\u2013265. https:\/\/doi.org\/10.1002\/1873-3468.14786","journal-title":"FEBS Lett"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-024-01719-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-024-01719-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-024-01719-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T15:06:35Z","timestamp":1736348795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-024-01719-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,26]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1719"],"URL":"https:\/\/doi.org\/10.1007\/s12105-024-01719-1","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,26]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required. This study has obtained IRB approval from the Institutional Review Board at the Massachusetts General Hospital (2013P001818, WCF).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This study has obtained IRB approval from the Institutional Review Board at the Massachusetts General Hospital (2013P001818, WCF) and the need for informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"For this type of study consent for publication is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"114"}}